GLOBAL SPASTIC PARAPLEGIA 50 MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Spastic Paraplegia 50 Market, By Treatment Type (Medication, Physiotherapy, Surgery, Assistive Devices, Others), By Route of Administration (Oral, Injectable, Topical, Others), By End User (Hospitals & Clinics, Rehab Centers, Home Care Settings), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)Global Spastic Paraplegia 50 Market, By Treatment Type (Medication, Physiotherapy, Surgery, Assistive Devices, Others), By Route of Administration (Oral, Injectable, Topical, Others), By End User (Hospitals & Clinics, Rehab Centers, Home Care Settings), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Global Spastic Paraplegia 50 Market- Recent Developments

Partnership Scenario

In September 2023, Viralgen Vector Core, a contract development and manufacturing organization (CDMO), and Elpida Therapeutics, a biotechnology research company, announced that they had partnered to manufacture gene therapies for use in clinical trials sponsored by Elpida Tx involving patients living with SPG50 or CMT4J. It is anticipated that these trials will take place at various sites in North America and Europe and will explore the potential safety and efficacy of the new treatments to be manufactured, as well as potential quality of life improvements.